Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 16 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Ekart, Robert  [Clear All Filters]
2020
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  Erratum.. Nephrol Dial Transplant. 35(8), 1452.
Loutradis, C., Papagianni A., Ekart R., Theodorakopoulou M., Minopoulou I., Pagourelias E., et al. (2020).  Excess volume removal following lung ultrasound evaluation decreases central blood pressure and pulse wave velocity in hemodialysis patients: a LUST sub-study.. J Nephrol. 33(6), 1289-1300.
Torino, C., Gargani L., Sicari R., Letachowicz K., Ekart R., Fliser D., et al. (2020).  Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study.. J Nephrol. 33(3), 583-590.
Loutradis, C., Papadopoulos C. E., Sachpekidis V., Ekart R., Krunic B., Karpetas A., et al. (2020).  Lung Ultrasound-Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study.. Am J Kidney Dis. 75(1), 11-20.
Potpara, T. S., Ferro C., Lip G. Y. H., Dan G. A., Lenarczyk R., Mallamaci F., et al. (2020).  Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based su. Europace. 22(3), 496-505.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Mallamaci, F., Torino C., Sarafidis P., Ekart R., Loutradis C., Siamopoulos K., et al. (2020).  Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study.. J Hypertens. 38(9), 1849-1856.
2019
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2019).  Author Correction: Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 15(2), 121.
Loutradis, C., Sarafidis P. A., Ekart R., Papadopoulos C., Sachpekidis V., Alexandrou M. Eleni, et al. (2019).  The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.. Kidney Int. 95(6), 1505-1513.
Loutradis, C., Sarafidis P. A., Theodorakopoulou M., Ekart R., Alexandrou M. Eleni, Pyrgidis N., et al. (2019).  Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability.. Am J Hypertens. 32(8), 786-795.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2019).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 34(9), 1542-1548.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.